These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21666220)

  • 1. Global eradication of measles: an epidemiologic and economic evaluation.
    Levin A; Burgess C; Garrison LP; Bauch C; Babigumira J; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S98-106. PubMed ID: 21666220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication program.
    Babigumira JB; Levin A; Burgess C; Garrison LP; Bauch CT; Braka F; Mbabazi WB; Nabyonga JO; Simons E; Dabbagh A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S116-23. PubMed ID: 21666152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.
    Garrison LP; Bauch CT; Bresnahan BW; Hazlet TK; Kadiyala S; Veenstra DL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S124-32. PubMed ID: 21666153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can measles eradication strengthen health care systems?
    Griffiths UK; Mounier-Jack S; Oliveira-Cruz V; Balabanova D; Hanvoravongchai P; Ongolo P
    J Infect Dis; 2011 Jul; 204 Suppl 1():S78-81. PubMed ID: 21666217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.
    Costa A; Henao-Restrepo AM; Marie Hall S; Jarrett S; Hoekstra EJ
    J Infect Dis; 2003 May; 187 Suppl 1():S22-8. PubMed ID: 12721888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategic planning for measles control: using data to inform optimal vaccination strategies.
    Simons E; Mort M; Dabbagh A; Strebel P; Wolfson L
    J Infect Dis; 2011 Jul; 204 Suppl 1():S28-34. PubMed ID: 21666174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global measles control and regional elimination, 1998-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Dec; 48(49):1124-30. PubMed ID: 10634347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future savings from measles eradication in industrialized countries.
    Carabin H; Edmunds WJ
    J Infect Dis; 2003 May; 187 Suppl 1():S29-35. PubMed ID: 12721889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward global measles control and regional elimination, 1990-1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Dec; 47(48):1049-54. PubMed ID: 9869078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing measles with previous eradication programs: enabling and constraining factors.
    Keegan R; Dabbagh A; Strebel PM; Cochi SL
    J Infect Dis; 2011 Jul; 204 Suppl 1():S54-61. PubMed ID: 21666211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
    Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: global measles control and mortality reduction--worldwide, 1991-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 May; 52(20):471-5. PubMed ID: 12807081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An economic evaluation of measles vaccination in District 3 of the city of Bucharest].
    Ion-Nedelcu N; Mihăileanu C; Dobrescu A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1989; 34(2):163-8. PubMed ID: 2506626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Americas: paving the road toward global measles eradication.
    Castillo-Solorzano C C; Matus CR; Flannery B; Marsigli C; Tambini G; Andrus JK
    J Infect Dis; 2011 Jul; 204 Suppl 1():S270-8. PubMed ID: 21666172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there enough vaccine to eradicate measles? An integrated analysis of measles-containing vaccine supply and demand.
    Smith G; Michelson J; Singh R; Dabbagh A; Hoekstra E; van den Ent M; Mallya A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S62-70. PubMed ID: 21666215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in reducing measles mortality--worldwide, 1999-2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Mar; 54(8):200-3. PubMed ID: 15744229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Measles Initiative: moving toward measles eradication.
    Christie AS; Gay A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S14-7. PubMed ID: 21666155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in reducing global measles deaths, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(9):247-9. PubMed ID: 16528234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in global measles control and mortality reduction, 2000-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Nov; 56(47):1237-41. PubMed ID: 18046301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.